Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients

NCT00781339 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Asymptomatic Bacteriuria

Interventions

DRUG: sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate

Sponsor

NovaBay Pharmaceuticals, Inc.